Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Olschewski

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Oncogene|March 18, 2014
PCK2 activation mediates an adaptive response to glucose depletion in lung cancerK Leithner, A Hrzenjak, M Trötzmüller, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Epigenetics and genetics of pulmonary arterial hypertension--new insights from the last years]G Kwapiszewska, R Rodríguez Viales, N Ehlken, et al.
British Journal of Pharmacology|May 1, 2014
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertensionS Crnkovic, B Egemnazarov, P Jain, et al.
British Journal of Pharmacology|June 24, 2015
Activation of EP<sub>4</sub> receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier functionV Konya, J Maric, K Jandl, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Pulmonary arterial hypertension--a disease of the immune system?]G Riemekasten, W M Kuebler, R Schermuly, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]A Olschewski, E M Berghausen, C A Eichstaedt, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncogene|March 18, 2014
PCK2 activation mediates an adaptive response to glucose depletion in lung cancerK Leithner, A Hrzenjak, M Trötzmüller, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Epigenetics and genetics of pulmonary arterial hypertension--new insights from the last years]G Kwapiszewska, R Rodríguez Viales, N Ehlken, et al.
British Journal of Pharmacology|May 1, 2014
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertensionS Crnkovic, B Egemnazarov, P Jain, et al.
British Journal of Pharmacology|June 24, 2015
Activation of EP<sub>4</sub> receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier functionV Konya, J Maric, K Jandl, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 2014
[Pulmonary arterial hypertension--a disease of the immune system?]G Riemekasten, W M Kuebler, R Schermuly, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]A Olschewski, E M Berghausen, C A Eichstaedt, et al.
Pageof 3